FendX and McMaster Collaborate on NSERC Alliance Grant Application for Pathogen-Repelling Spray Nanotechnology Scale-up Development

Oakville, Ontario–(Newsfile Corp. – March 15, 2024) – FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a nanotechnology company developing surface protection coatings to reduce the spread of pathogens, is pleased to announce that McMaster University (“McMaster”) has submitted an application for a Natural Sciences and Engineering Council (“NSERC”) Alliance grant with FendX as the industry sponsor.

FendX, in collaboration with McMaster, has been advancing development of the spray formulation which it licensed from McMaster as announced on May 17, 2023. If awarded, this NSERC Alliance grant will contribute to funding the advancement of the spray nanotechnology, including scale-up and testing, as FendX continues to pursue the development of a commercial spray product to protect high-touch surfaces from contamination and curb the spread of pathogens.

Dr. Carolyn Myers, CEO of FendX states “We are pleased with our successful collaboration with McMaster and as we jointly advance our development programs, we support sponsoring grants that can contribute to funding for the advancement of our products under development.” Dr. Myers continues “If granted, this would mark the second NSERC Alliance grant received by McMaster with FendX as the industry sponsor. The initial grant, awarded in May 2022, supports the development and scale-up of our innovative product REPELWRAP™ film.”

About FendX Technologies Inc.

FendX is a Canada-based nanotechnology company focused on developing products to make people’s lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has an exclusive worldwide license to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.

ON BEHALF OF THE BOARD

“Carolyn Myers”
Carolyn Myers
Chief Executive Officer and Director

Contacts:
Dr. Carolyn Myers, CEO and Director
1-800-344-9868

Alyssa Barry, Investor Relations
1-833-947-5227
investor@fendxtech.com

For more information, please visit https://fendxtech.com/ and the Company’s profile on SEDAR+ at www.sedarplus.ca.

Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; the award of funds pursuant to the NSERC Grant application; statements that the NSERC Alliance grant will contribute to funding the advancement of the spray nanotechnology, including scale-up and testing; statements regarding FendX continuing to pursue the development of a commercial spray product to protect high-touch surfaces from contamination and curb the spread of pathogens; the continued advancement of our R&D and scale-up efforts on our nanotechnology; and products under development and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “aims,” “potential,” “goal,” “objective,” “prospective,” and similar expressions, or that events or conditions “will,” “would,” “may,” “can,” “could” or “should” occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made and involve several risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and that actual results and future events could differ materially from those anticipated in such statements.

Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other risk factors set forth in the Company’s public filings which are available on SEDAR+ at www.sedarplus.ca. Accordingly, the reader is urged to refer to the Company’s such filings for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management’s beliefs, estimates or opinions, or other factors should change.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/201900